Insider Trading Activity CONMED Corporation (NASDAQ:CNMD) – Director Sold 3,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For CONMED Corporation (NASDAQ:CNMD)

Jo Ann Golden , Director of CONMED Corporation (NASDAQ:CNMD) reportedly Sold 3,000 shares of the company’s stock at an average price of 50 for a total transaction amount of $150,000.00 SEC Form

Insider Trading History For CONMED Corporation (NASDAQ:CNMD)

  • On 2/15/2013 Stuart J Schwartz, Director, sold 1,000 with an average share price of $30.32 per share and the total transaction amounting to $30,320.00.View SEC Filing
  • On 5/28/2013 Robert D Shallish Jr, CFO, sold 10,000 with an average share price of $34.35 per share and the total transaction amounting to $343,500.00.View SEC Filing
  • On 5/29/2013 Heather L Cohen, VP, sold 4,514 with an average share price of $34.31 per share and the total transaction amounting to $154,875.34.View SEC Filing
  • On 5/31/2013 Luke A Pomilio, VP, sold 2,556 with an average share price of $33.19 per share and the total transaction amounting to $84,833.64.View SEC Filing
  • On 6/4/2013 Heather L Cohen, VP, sold 1,200 with an average share price of $32.59 per share and the total transaction amounting to $39,108.00.View SEC Filing
  • On 6/7/2013 Daniel Jonas, VP, sold 2,000 with an average share price of $32.42 per share and the total transaction amounting to $64,840.00.View SEC Filing
  • On 8/15/2013 Dirk Kuyper, Director, bought 1,000 with an average share price of $31.63 per share and the total transaction amounting to $31,630.00.View SEC Filing

    • Analyst Ratings For CONMED Corporation (NASDAQ:CNMD)
    These are 2 Hold Ratings, 1 Buy Rating .
    The current consensus rating for CONMED Corporation (NASDAQ:CNMD) is Hold (Score: 2.33) with a consensus target price of $49.33 , a potential (1.23% downside)

    Analyst Ratings History For CONMED Corporation (NASDAQ:CNMD)

    • On 8/27/2015 Piper Jaffray Companies Reiterated Rating Neutral with a price target of $51.00
    • On 10/22/2015 Northland Securities Lower Price Target of rating Market Perform with a price target of $58.00 to $44.00
    • On 11/17/2015 Deutsche Bank AG Reiterated Rating Buy
    • On 11/23/2016 Leerink Swann Reiterated Rating Hold to Neutral
    • On 4/27/2017 Ladenburg Thalmann Financial Services Downgraded rating Buy to Neutral with a price target of $50.00 to $48.00
    • On 7/27/2017 Needham & Company LLC Boost Price Target of rating Buy to Buy with a price target of $54.00 to $57.00

    Dividend Information For CONMED Corporation (NASDAQ:CNMD)
    CONMED Corporation (NASDAQ:CNMD) pays an annual dividend of Community Ranking: with a yield of Community Ranking:

    Dividend History For CONMED Corporation (NASDAQ:CNMD)

  • On 2/27/2013 CONMED Corporation announced a quarterly dividend of $0.15 1.93% with an ex dividend date of 3/13/2013 which will be payable on 4/5/2013.
  • On 5/24/2013 CONMED Corporation announced a quarterly dividend of $0.15 1.76% with an ex dividend date of 6/13/2013 which will be payable on 7/8/2013.
  • On 8/27/2013 CONMED Corporation announced a quarterly dividend of $0.15 1.91% with an ex dividend date of 9/12/2013 which will be payable on 10/4/2013.
  • On 10/28/2013 CONMED Corporation announced a quarterly dividend of $0.20 with an ex dividend date of 12/12/2013 which will be payable on 1/6/2014.
  • On 2/27/2014 CONMED Corporation announced a quarterly dividend of $0.20 1.72% with an ex dividend date of 3/13/2014 which will be payable on 4/7/2014.
  • On 5/23/2014 CONMED Corporation announced a quarterly dividend of $0.20 1.8% with an ex dividend date of 6/12/2014 which will be payable on 7/7/2014.
  • On 8/25/2014 CONMED Corporation announced a quarterly dividend of $0.20 2.11% with an ex dividend date of 9/11/2014 which will be payable on 10/6/2014.

    • Recent Trading Activity for CONMED Corporation (NASDAQ:CNMD)
    Shares of CONMED Corporation closed the previous trading session at 49.95 down -0.19 -0.38% with 59,249 shares trading hands.